These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37760474)

  • 1. Validation of a Proteomic Signature of Lung Cancer Risk from Bronchial Specimens of Risk-Stratified Individuals.
    Rahman SMJ; Chen SC; Wang YT; Gao Y; Schepmoes AA; Fillmore TL; Shi T; Chen H; Rodland KD; Massion PP; Grogan EL; Liu T
    Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The airway epithelium undergoes metabolic reprogramming in individuals at high risk for lung cancer.
    Rahman SMJ; Ji X; Zimmerman LJ; Li M; Harris BK; Hoeksema MD; Trenary IA; Zou Y; Qian J; Slebos RJ; Beane J; Spira A; Shyr Y; Eisenberg R; Liebler DC; Young JD; Massion PP
    JCI Insight; 2016 Nov; 1(19):e88814. PubMed ID: 27882349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of MCM7 expression in the bronchial brushings of patients with non-small cell lung cancer (NSCLC).
    Liu YZ; Jiang YY; Hao JJ; Lu SS; Zhang TT; Shang L; Cao J; Song X; Wang BS; Cai Y; Zhan QM; Wang MR
    Lung Cancer; 2012 Jul; 77(1):176-82. PubMed ID: 22456526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A panel of protein markers for the early detection of lung cancer with bronchial brushing specimens.
    Liu YZ; Jiang YY; Wang BS; Hao JJ; Shang L; Zhang TT; Cao J; Xu X; Zhan QM; Wang MR
    Cancer Cytopathol; 2014 Nov; 122(11):833-41. PubMed ID: 25045014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Proteomic Features To Distinguish Benign Pulmonary Nodules from Lung Adenocarcinoma.
    Codreanu SG; Hoeksema MD; Slebos RJC; Zimmerman LJ; Rahman SMJ; Li M; Chen SC; Chen H; Eisenberg R; Liebler DC; Massion PP
    J Proteome Res; 2017 Sep; 16(9):3266-3276. PubMed ID: 28731711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of trisomy 7 in nonmalignant bronchial epithelium from lung cancer patients and individuals at risk for lung cancer.
    Crowell RE; Gilliland FD; Temes RT; Harms HJ; Neft RE; Heaphy E; Auckley DH; Crooks LA; Jordan SW; Samet JM; Lechner JF; Belinsky SA
    Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):631-7. PubMed ID: 8824366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A potential probe set of fluorescence in situ hybridization for detection of lung cancer in bronchial brushing specimens.
    Liu YZ; Wang Z; Fang LL; Li L; Cao J; Xu X; Han YL; Cai Y; Wang LX; Wang MR
    J Cancer Res Clin Oncol; 2012 Sep; 138(9):1541-9. PubMed ID: 22538453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A lung cancer risk classifier comprising genome maintenance genes measured in normal bronchial epithelial cells.
    Yeo J; Crawford EL; Zhang X; Khuder S; Chen T; Levin A; Blomquist TM; Willey JC
    BMC Cancer; 2017 May; 17(1):301. PubMed ID: 28464886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 25-signal proteomic signature and outcome for patients with resected non-small-cell lung cancer.
    Yanagisawa K; Tomida S; Shimada Y; Yatabe Y; Mitsudomi T; Takahashi T
    J Natl Cancer Inst; 2007 Jun; 99(11):858-67. PubMed ID: 17551146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in Bronchial Airway miRNA Expression for Lung Cancer Detection.
    Pavel AB; Campbell JD; Liu G; Elashoff D; Dubinett S; Smith K; Whitney D; Lenburg ME; Spira A;
    Cancer Prev Res (Phila); 2017 Nov; 10(11):651-659. PubMed ID: 28877936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of lung cancer in bronchial brushing specimens by FISH.
    Voss JS; Kipp BR; Halling KC
    Expert Rev Mol Diagn; 2012 Sep; 12(7):679-81. PubMed ID: 23153235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large-Scale SRM Screen of Urothelial Bladder Cancer Candidate Biomarkers in Urine.
    Duriez E; Masselon CD; Mesmin C; Court M; Demeure K; Allory Y; Malats N; Matondo M; Radvanyi F; Garin J; Domon B
    J Proteome Res; 2017 Apr; 16(4):1617-1631. PubMed ID: 28287737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two microRNA panels to discriminate three subtypes of lung carcinoma in bronchial brushing specimens.
    Huang W; Hu J; Yang DW; Fan XT; Jin Y; Hou YY; Wang JP; Yuan YF; Tan YS; Zhu XZ; Bai CX; Wu Y; Zhu HG; Lu SH
    Am J Respir Crit Care Med; 2012 Dec; 186(11):1160-7. PubMed ID: 23043084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of lung cancer: a bronchoscopist's perspective.
    Griffin JP; Zaman MK; Niell HB; Tolley EA; Cole FH; Weiman DS
    J Bronchology Interv Pulmonol; 2012 Jan; 19(1):12-8. PubMed ID: 23207257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The optimal sequence for bronchial brushing and forceps biopsy in lung cancer diagnosis: a random control study.
    Hou G; Miao Y; Hu XJ; Wang W; Wang QY; Wu GP; Wang EH; Kang J
    J Thorac Dis; 2016 Mar; 8(3):520-6. PubMed ID: 27076949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATAQS: A computational software tool for high throughput transition optimization and validation for selected reaction monitoring mass spectrometry.
    Brusniak MY; Kwok ST; Christiansen M; Campbell D; Reiter L; Picotti P; Kusebauch U; Ramos H; Deutsch EW; Chen J; Moritz RL; Aebersold R
    BMC Bioinformatics; 2011 Mar; 12():78. PubMed ID: 21414234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneous nuclear ribonucleoprotein A2/B1 up-regulation in bronchial lavage specimens: a clinical marker of early lung cancer detection.
    Fielding P; Turnbull L; Prime W; Walshaw M; Field JK
    Clin Cancer Res; 1999 Dec; 5(12):4048-52. PubMed ID: 10632338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted proteomics for biomarker discovery and validation of hepatocellular carcinoma in hepatitis C infected patients.
    Mustafa GM; Larry D; Petersen JR; Elferink CJ
    World J Hepatol; 2015 Jun; 7(10):1312-24. PubMed ID: 26052377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-depth proteomics of ovarian cancer ascites: combining shotgun proteomics and selected reaction monitoring mass spectrometry.
    Elschenbroich S; Ignatchenko V; Clarke B; Kalloger SE; Boutros PC; Gramolini AO; Shaw P; Jurisica I; Kislinger T
    J Proteome Res; 2011 May; 10(5):2286-99. PubMed ID: 21491939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of molecular abnormalities in bronchial brushings and tumor touch preparations.
    Barkan GA; Caraway NP; Jiang F; Zaidi TM; Fernandez R; Vaporcyin A; Morice R; Zhou X; Bekele BN; Katz RL
    Cancer; 2005 Feb; 105(1):35-43. PubMed ID: 15605362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.